Phreesia, Inc.
PHR
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $676.2M
$10.94
▼ -1.44%
P/E
64.70
Mkt Cap
$676.2M
52-Wk Range
$7.77–$28.89
52-Week Range
$7.77 - $28.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 59.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated platform combining intake, payments, and clinical workflows reduces vendor fragmentation
- Multi-modal deployment (mobile, web, kiosks) provides flexibility and broad market reach
- Recurring SaaS revenue model with high customer switching costs and sticky relationships
- Extensive healthcare specialization expertise across 25+ clinical specialties
- Embedded payment processing creates additional revenue streams and customer lock-in
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Digital transformation acceleration in healthcare post-COVID-19
Value
Significant premium - growth priced in
Momentum
Strong
+17.1% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying PHR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
SEP 2, 2026
Reported EPS of $0.03 vs $0.09 consensus (-64.7% surprise). Revenue of $129.5M vs $129.1M expected (+0.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-64.7%
Revenue trend · last 8Q
—
+15%
+15%
+15%
+13%
+16%
+13%
+10%
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q4 26
Q1 27
Q2 27
$106.8M
$109.7M
$115.9M
$117.3M
$120.3M
$127.1M
$130.9M
$129.5M
Margins · last 8Q
Gross
85.1%
Operating
5.9%
Profit
3.5%
Wall Street consensus
14 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Citi · Sep 4, 2026
vs Industry
How PHR stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related